Tumor
-
Agenus UNICORN Trial Shows Immunotherapy Cures Resectable Colon Cancer
New data from Agenus’ UNICORN trial reveals that short-course neoadjuvant immunotherapy achieves pathologic complete responses in 93% of dMMR colon cancer patients,…
Most read
-
Martin Lewis Warns Savers With £10,000 or More They Could Owe Tax on Interest
-
Selangor International Care Expo 2026 Targets the Growing Care Economy
-
Asian & Oceanian Epilepsy Congress 2026 in Kuala Lumpur
-
Baby & Beyond Maternity Expo in Kuala Lumpur 2026
-
Axos Offers 5.00% Savings Rate for Six Months After Fed Hike, With Strings Attached
-
Agenus UNICORN Trial Shows Immunotherapy Cures Resectable Colon Cancer
-
Study Links High Sugar Intake to 28% Higher Breast Cancer Risk in Korean Women
-
Generic HIV Shot Cuts Cost to $40, Unlocking Access in 120 Low-Income Countries
-
AI Paper Mills Flood Journals With Unverifiable Health Studies, Researchers Warn
-
Major study links moderate alcohol consumption to increased cancer risk and early death
-
Personal Factors Driving Cancer Biomarker Decisions and Patient Outcomes
-
RBA Hike to 4.85% Adds $107 to Monthly Mortgage Repayments for Homeowners
-
Affluent Investors Over 60 Face Tax Risks When Splitting Assets
-
Nicole Eggert’s Cancer Bills and a Trial That Cut Financial Toxicity for Patients
-
Why Retirees Must Shift Emergency Fund Strategies Beyond Standard Three-Month Rules
-
BMS GPRC5D CAR-T Arlo-cel Shows Deep Responses After BCMA Failure
-
Understanding the FDA’s Accelerated Approval of Iberdomide for Multiple Myeloma
-
Rockefeller’s 2141-V11 Trial Shows Complete Remission in Two Metastatic Cancer Patients
-
Ellie Sullivan: Genetic Testing Refused for a Decade, Then Offered After Her Diagnosis
-
Personalized mRNA Cancer Vaccine Succeeds in First Phase 3 Melanoma Trial
-
Indiana University Study Ties Delayed Colorectal Cancer Treatment to Higher Metastasis Risk
-
Study: People Who Drank More Water With Meals Ate More Food, Not Less
-
Why Mornings Are Hardest With ADHD: Late Body Clocks, Poor Sleep and Dopamine
-
Immunotherapy and Genome-Based Vaccines Put the Immune System to Work Against Disease
-
Geneticist John Hardy Proposed Alzheimer’s Amyloid Hypothesis in 1992